174 related articles for article (PubMed ID: 27669574)
1. Binding Site Geometry and Subdomain Valency Control Effects of Neutralizing Lectins on HIV-1 Viral Particles.
Lusvarghi S; Lohith K; Morin-Leisk J; Ghirlando R; Hinshaw JE; Bewley CA
ACS Infect Dis; 2016 Nov; 2(11):882-891. PubMed ID: 27669574
[TBL] [Abstract][Full Text] [Related]
2. The role of individual carbohydrate-binding sites in the function of the potent anti-HIV lectin griffithsin.
Xue J; Gao Y; Hoorelbeke B; Kagiampakis I; Zhao B; Demeler B; Balzarini J; Liwang PJ
Mol Pharm; 2012 Sep; 9(9):2613-25. PubMed ID: 22827601
[TBL] [Abstract][Full Text] [Related]
3. The lectins griffithsin, cyanovirin-N and scytovirin inhibit HIV-1 binding to the DC-SIGN receptor and transfer to CD4(+) cells.
Alexandre KB; Gray ES; Mufhandu H; McMahon JB; Chakauya E; O'Keefe BR; Chikwamba R; Morris L
Virology; 2012 Feb; 423(2):175-86. PubMed ID: 22209231
[TBL] [Abstract][Full Text] [Related]
4. Removal of two high-mannose N-linked glycans on gp120 renders human immunodeficiency virus 1 largely resistant to the carbohydrate-binding agent griffithsin.
Huang X; Jin W; Griffin GE; Shattock RJ; Hu Q
J Gen Virol; 2011 Oct; 92(Pt 10):2367-2373. PubMed ID: 21715597
[TBL] [Abstract][Full Text] [Related]
5. Solution structure of the monovalent lectin microvirin in complex with Man(alpha)(1-2)Man provides a basis for anti-HIV activity with low toxicity.
Shahzad-ul-Hussan S; Gustchina E; Ghirlando R; Clore GM; Bewley CA
J Biol Chem; 2011 Jun; 286(23):20788-96. PubMed ID: 21471192
[TBL] [Abstract][Full Text] [Related]
6. The barley lectin, horcolin, binds high-mannose glycans in a multivalent fashion, enabling high-affinity, specific inhibition of cellular HIV infection.
Jayaprakash NG; Singh A; Vivek R; Yadav S; Pathak S; Trivedi J; Jayaraman N; Nandi D; Mitra D; Surolia A
J Biol Chem; 2020 Aug; 295(34):12111-12129. PubMed ID: 32636304
[No Abstract] [Full Text] [Related]
7. High-Mannose Specific Lectin and Its Recombinants from a Carrageenophyta Kappaphycus alvarezii Represent a Potent Anti-HIV Activity Through High-Affinity Binding to the Viral Envelope Glycoprotein gp120.
Hirayama M; Shibata H; Imamura K; Sakaguchi T; Hori K
Mar Biotechnol (NY); 2016 Apr; 18(2):215-31. PubMed ID: 26661793
[TBL] [Abstract][Full Text] [Related]
8. Cyanovirin-N binds to gp120 to interfere with CD4-dependent human immunodeficiency virus type 1 virion binding, fusion, and infectivity but does not affect the CD4 binding site on gp120 or soluble CD4-induced conformational changes in gp120.
Esser MT; Mori T; Mondor I; Sattentau QJ; Dey B; Berger EA; Boyd MR; Lifson JD
J Virol; 1999 May; 73(5):4360-71. PubMed ID: 10196334
[TBL] [Abstract][Full Text] [Related]
9. Accessibility of the high-mannose glycans of glycoprotein gp120 from human immunodeficiency virus type 1 probed by in vitro interaction with mannose-binding lectins.
Astoul CH; Peumans WJ; Van Damme EJ; Roug
Biochem Biophys Res Commun; 2000 Aug; 274(2):455-60. PubMed ID: 10913359
[TBL] [Abstract][Full Text] [Related]
10. HIV-1 envelope trimer has similar binding characteristics for carbohydrate-binding agents as monomeric gp120.
Hoorelbeke B; van Montfort T; Xue J; LiWang PJ; Tanaka H; Igarashi Y; Van Damme EJ; Sanders RW; Balzarini J
FEBS Lett; 2013 Apr; 587(7):860-6. PubMed ID: 23454641
[TBL] [Abstract][Full Text] [Related]
11. Restricted HIV-1 Env glycan engagement by lectin-reengineered DAVEI protein chimera is sufficient for lytic inactivation of the virus.
Parajuli B; Acharya K; Bach HC; Parajuli B; Zhang S; Smith AB; Abrams CF; Chaiken I
Biochem J; 2018 Mar; 475(5):931-957. PubMed ID: 29343613
[TBL] [Abstract][Full Text] [Related]
12. Glycosylation and oligomeric state of envelope protein might influence HIV-1 virion capture by α4β7 integrin.
Chand S; Messina EL; AlSalmi W; Ananthaswamy N; Gao G; Uritskiy G; Padilla-Sanchez V; Mahalingam M; Peachman KK; Robb ML; Rao M; Rao VB
Virology; 2017 Aug; 508():199-212. PubMed ID: 28577856
[TBL] [Abstract][Full Text] [Related]
13. Antigenic properties of the human immunodeficiency virus envelope glycoprotein gp120 on virions bound to target cells.
Mengistu M; Ray K; Lewis GK; DeVico AL
PLoS Pathog; 2015 Mar; 11(3):e1004772. PubMed ID: 25807494
[TBL] [Abstract][Full Text] [Related]
14. Mechanism by which the lectin actinohivin blocks HIV infection of target cells.
Tanaka H; Chiba H; Inokoshi J; Kuno A; Sugai T; Takahashi A; Ito Y; Tsunoda M; Suzuki K; Takénaka A; Sekiguchi T; Umeyama H; Hirabayashi J; Omura S
Proc Natl Acad Sci U S A; 2009 Sep; 106(37):15633-8. PubMed ID: 19717426
[TBL] [Abstract][Full Text] [Related]
15. Chemical and Biophysical Approaches for Complete Characterization of Lectin-Carbohydrate Interactions.
Lusvarghi S; Ghirlando R; Davison JR; Bewley CA
Methods Enzymol; 2018; 598():3-35. PubMed ID: 29306440
[TBL] [Abstract][Full Text] [Related]
16. Potent strategy to inhibit HIV-1 by binding both gp120 and gp41.
Kagiampakis I; Gharibi A; Mankowski MK; Snyder BA; Ptak RG; Alatas K; LiWang PJ
Antimicrob Agents Chemother; 2011 Jan; 55(1):264-75. PubMed ID: 20956603
[TBL] [Abstract][Full Text] [Related]
17. A recombinant allosteric lectin antagonist of HIV-1 envelope gp120 interactions.
McFadden K; Cocklin S; Gopi H; Baxter S; Ajith S; Mahmood N; Shattock R; Chaiken I
Proteins; 2007 May; 67(3):617-29. PubMed ID: 17348010
[TBL] [Abstract][Full Text] [Related]
18. Cyanovirin-N Binds Viral Envelope Proteins at the Low-Affinity Carbohydrate Binding Site without Direct Virus Neutralization Ability.
Maier I; Schiestl RH; Kontaxis G
Molecules; 2021 Jun; 26(12):. PubMed ID: 34199200
[TBL] [Abstract][Full Text] [Related]
19. Potent inhibition of HIV-1 fusion by cyanovirin-N requires only a single high affinity carbohydrate binding site: characterization of low affinity carbohydrate binding site knockout mutants.
Chang LC; Bewley CA
J Mol Biol; 2002 Apr; 318(1):1-8. PubMed ID: 12054763
[TBL] [Abstract][Full Text] [Related]
20. Correlation between carbohydrate structures on the envelope glycoprotein gp120 of HIV-1 and HIV-2 and syncytium inhibition with lectins.
Hansen JE; Nielsen CM; Nielsen C; Heegaard P; Mathiesen LR; Nielsen JO
AIDS; 1989 Oct; 3(10):635-41. PubMed ID: 2574581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
